Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism IL-33R inhibitors(Interleukin-1 receptor-like 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | VN | 15 Jan 2022 | |
Inflammation | Preclinical | VN | 15 Jan 2022 |